For the quarter ending 2026-03-31, ABCL has $1,307,112K in assets. $369,029K in debts. $77,063K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 77,063 | 128,513 | 83,159 | 92,437 |
| Marketable securities | 427,669 | 405,313 | 412,513 | 460,641 |
| Total cash, cash equivalents, and marketable securities | 504,732 | 533,826 | 495,672 | 553,078 |
| Accounts and accrued receivable | 36,761 | 58,293 | 41,456 | 47,310 |
| Restricted cash | 25,000 | 25,000 | 25,000 | 25,000 |
| Other current assets | 98,103 | 111,113 | 133,012 | 116,757 |
| Total current assets | 664,596 | 728,232 | 695,140 | 742,145 |
| Property and equipment, net | 422,806 | 428,003 | 427,358 | 424,020 |
| Gross carrying amount | 69,320 | 69,320 | 91,133 | - |
| Accumulated amortization | 31,860 | 30,939 | 51,812 | - |
| Intangible assets, net | 37,460 | 38,381 | 39,321 | 40,262 |
| Goodwill | 47,806 | 47,806 | 47,806 | 47,806 |
| Investments in equity accounted investees | 65,308 | 62,580 | 93,301 | 90,374 |
| Other long-term assets | 69,136 | 51,948 | 53,066 | 57,454 |
| Total long-term assets | 642,516 | 628,718 | 660,852 | 659,916 |
| Total assets | 1,307,112 | 1,356,950 | 1,355,992 | 1,402,061 |
| Accounts payable and other current liabilities | 39,551 | 50,781 | 53,117 | 50,074 |
| Contingent consideration payable | - | 0 | 0 | 0 |
| Deferred revenue | 7,743 | 13,526 | 15,687 | 16,949 |
| Total current liabilities | 47,294 | 64,307 | 68,804 | 67,023 |
| Operating lease liability | 134,309 | 137,403 | 137,052 | 137,184 |
| Deferred tax liability | - | 9,115 | 9,744 | 10,053 |
| Deferred revenue | - | - | 5,850 | 11,633 |
| Deferred government contributions | 176,105 | 174,453 | 169,118 | 167,532 |
| Other long-term liabilities | 11,321 | 4,768 | 1,386 | 1,560 |
| Total long-term liabilities | 321,735 | 325,739 | 323,150 | 327,962 |
| Total liabilities | 369,029 | 390,046 | 391,954 | 394,985 |
| Common shares no par value, unlimited authorized shares at december31, 2025 and march31, 2026 300,600,710 and 303,945,581 shares issued and outstanding at december31, 2025 and march31, 2026, respectively | 816,533 | 802,341 | 794,469 | 791,668 |
| Additional paid-in capital | 196,616 | 198,279 | 192,804 | 181,483 |
| Accumulated other comprehensive loss | -2,419 | -4,234 | -2,698 | -2,657 |
| Accumulated deficit | -72,647 | -29,482 | -20,537 | 36,582 |
| Total shareholders' equity | 938,083 | 966,904 | 964,038 | 1,007,076 |
| Total liabilities and shareholders' equity | 1,307,112 | 1,356,950 | 1,355,992 | 1,402,061 |
AbCellera Biologics Inc. (ABCL)
AbCellera Biologics Inc. (ABCL)